Literature DB >> 17490747

Biological aspects of ceramide-enriched membrane domains.

Heike Grassmé1, Joachim Riethmüller, Erich Gulbins.   

Abstract

Ceramide has been shown to be critically involved in many aspects of cellular responses to receptor-dependent and -independent stimuli. For instance, ceramide was demonstrated to be a central component of the signaling cascades mediating apoptosis after death receptor stimulation, treatment with chemotherapy or exposure to gamma-irradiation or UV-A light. Further studies indicated the importance of ceramide for the infection of mammalian cells with bacterial, viral and parasitic pathogens. Ceramide is released by the activity of acid, neutral or alkaline sphingomyelinases or de novo synthesized. A concept unifying the diverse biological functions of ceramide indicates that ceramide forms distinct membrane domains, named ceramide-enriched membrane domains or platforms. These domains serve the clustering of receptor molecules, the re-organization of signaling proteins, the exclusion of inhibitory signals and, thus, initiate and greatly amplify a primary signal. In addition, ceramide directly interacts with and stimulates intracellular enzymes that may act together with signals initiated in ceramide-enriched membrane domains to transmit signals into a cell.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17490747     DOI: 10.1016/j.plipres.2007.03.002

Source DB:  PubMed          Journal:  Prog Lipid Res        ISSN: 0163-7827            Impact factor:   16.195


  68 in total

Review 1.  Revitalizing membrane rafts: new tools and insights.

Authors:  Kai Simons; Mathias J Gerl
Journal:  Nat Rev Mol Cell Biol       Date:  2010-10       Impact factor: 94.444

Review 2.  GBA-Associated Parkinson's Disease and Other Synucleinopathies.

Authors:  Ziv Gan-Or; Christopher Liong; Roy N Alcalay
Journal:  Curr Neurol Neurosci Rep       Date:  2018-06-08       Impact factor: 5.081

3.  Coexistence of immiscible mixtures of palmitoylsphingomyelin and palmitoylceramide in monolayers and bilayers.

Authors:  Jon V Busto; María Laura Fanani; Luisina De Tullio; Jesús Sot; Bruno Maggio; Félix M Goñi; Alicia Alonso
Journal:  Biophys J       Date:  2009-11-18       Impact factor: 4.033

Review 4.  The role of ceramides in metabolic disorders: when size and localization matters.

Authors:  Sarah M Turpin-Nolan; Jens C Brüning
Journal:  Nat Rev Endocrinol       Date:  2020-02-14       Impact factor: 43.330

5.  Acid ceramidase improves the quality of oocytes and embryos and the outcome of in vitro fertilization.

Authors:  Efrat Eliyahu; Nataly Shtraizent; Kurt Martinuzzi; Jason Barritt; Xingxuan He; Hong Wei; Sanjeev Chaubal; Alan B Copperman; Edward H Schuchman
Journal:  FASEB J       Date:  2009-12-09       Impact factor: 5.191

Review 6.  The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases.

Authors:  Eric L Smith; Edward H Schuchman
Journal:  FASEB J       Date:  2008-06-20       Impact factor: 5.191

7.  Ceramide acyl chain length markedly influences miscibility with palmitoyl sphingomyelin in bilayer membranes.

Authors:  Bodil Westerlund; Pia-Maria Grandell; Y Jenny E Isaksson; J Peter Slotte
Journal:  Eur Biophys J       Date:  2009-11-12       Impact factor: 1.733

8.  Ceramide activates JNK to inhibit a cAMP-gated K+ conductance and Cl- secretion in intestinal epithelia.

Authors:  David E Saslowsky; Noriyuki Tanaka; Krishna P Reddy; Wayne I Lencer
Journal:  FASEB J       Date:  2008-09-26       Impact factor: 5.191

9.  Stress-induced sphingolipid signaling: role of type-2 neutral sphingomyelinase in murine cell apoptosis and proliferation.

Authors:  Raphael Devillard; Sylvain Galvani; Jean-Claude Thiers; Jean-Louis Guenet; Yusuf Hannun; Jacek Bielawski; Anne Nègre-Salvayre; Robert Salvayre; Nathalie Augé
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

10.  Induction of membrane ceramides: a novel strategy to interfere with T lymphocyte cytoskeletal reorganisation in viral immunosuppression.

Authors:  Evelyn Gassert; Elita Avota; Harry Harms; Georg Krohne; Erich Gulbins; Sibylle Schneider-Schaulies
Journal:  PLoS Pathog       Date:  2009-10-16       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.